| Craig M Kornbluth, MD | |
|
1746 Cole Blvd, Suite 150, Lakewood, CO 80401-3208 | |
| (303) 914-8800 | |
| (303) 716-3777 |
| Full Name | Craig M Kornbluth |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 1746 Cole Blvd, Lakewood, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134130925 | NPI | - | NPPES |
| 54988063 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 41480 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian St Luke's Medical Center | Denver, CO | Hospital |
| Rose Medical Center | Denver, CO | Hospital |
| St James Healthcare | Butte, MT | Hospital |
| St Francis-downtown | Greenville, SC | Hospital |
| Saint Joseph Hospital | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diversified Radiology Of Colorado Inc | 0143132316 | 84 |
| Orthopedic Centers Of Colorado | 2365714540 | 298 |
| Spectrum Medical Imaging Llc | 1355647595 | 47 |
| Upstate Carolina Radiology Pa | 0941298244 | 63 |
| Vail Clinic Inc | 3577475714 | 164 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Vail Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992812333 PECOS PAC ID: 3577475714 Enrollment ID: O20031105000224 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Diversified Radiology Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205923596 PECOS PAC ID: 0143132316 Enrollment ID: O20031105000319 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Charlotte Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649220443 PECOS PAC ID: 4587577390 Enrollment ID: O20131125001006 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Spectrum Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164881652 PECOS PAC ID: 1355647595 Enrollment ID: O20160314001910 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Radiology Ltd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841261989 PECOS PAC ID: 6204727589 Enrollment ID: O20170109002949 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Orthopedic Centers Of Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Upstate Carolina Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750348595 PECOS PAC ID: 0941298244 Enrollment ID: O20200415000237 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Windsong Radiology Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821048562 PECOS PAC ID: 0749264752 Enrollment ID: O20210802003302 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20231206000941 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig M Kornbluth, MD 1746 Cole Blvd, Suite 150, Lakewood, CO 80401-3208 Ph: (303) 914-8800 | Craig M Kornbluth, MD 1746 Cole Blvd, Suite 150, Lakewood, CO 80401-3208 Ph: (303) 914-8800 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories.
Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.
Valsalva (VLPP) and cough (CLPP) leak point pressures have been used for evaluating urinary incontinence in women. The relationship between these leak point pressures and stress urinary incontinence and detrusor overactivity is not known.
› Verified 5 days ago
Arthur Harvey Donahue, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 1746 Cole Blvd Ste 150, Lakewood, CO 80401 Phone: 303-914-8800 Fax: 303-716-3777 | |
Dr. Jeffrey Martin Albert, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11750 W 2nd Pl Ste 150, Lakewood, CO 80228 Phone: 720-321-8800 Fax: 720-321-8801 | |
Dr. John B Whitaker, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12687 W Cedar Dr Ste 200, Lakewood, CO 80228 Phone: 303-468-1395 | |
Justin S Clark, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1746 Cole Blvd Ste 150, Lakewood, CO 80401 Phone: 303-914-8800 | |
Dr. Clinton M Anderson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11600 W 2nd Pl, Lakewood, CO 80228 Phone: 720-321-0000 Fax: 720-321-1621 | |
Dr. Jayden A Spencer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1746 Cole Blvd Ste 150, Lakewood, CO 80401 Phone: 303-914-8800 Fax: 303-716-3777 | |
Dr. Steven P Ross, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11600 W 2nd Pl, Lakewood, CO 80228 Phone: 720-321-0000 Fax: 720-321-1621 |